Tablet (Immediate Release Scored Disc) · Methylphenidate hydrochloride
Canaryl
Methylphenidate hydrochloride in an immediate-release tablet (10 mg target). Rapidly elevates available prefrontal dopamine and norepinephrine to clear morning friction and initiate complex projects cleanly.
- 10 mg
- Target morning payload for immediate engagement.
- 20-30 min
- Fast onset with a focused 3 to 4 hour working arc.
- Clean
- Acute working drive without vesicular neurotransmitter depletion.
Action & Kinetics
Canaryl acts extracellularly by binding directly to dopamine transporter (DAT) and norepinephrine transporter (NET) proteins. By blocking the re-uptake of naturally released monoamines back into presynaptic terminals, it cleanly raises neurotransmitter concentrations in the synaptic cleft. This provides immediate initiation drive and mental clarity without depleting intracellular vesicular reserves.
- Active MoleculeMethylphenidate hydrochloride
- Delivery SystemTablet (Immediate Release Scored Disc)
- Nominal Payload10 mg target
- Therapeutic Timing20 to 30 minute onset, 3 to 4 hour duration
Primary Clinical Effects
- Rapid Morning EngagementEngages working memory and analytical clarity within twenty to thirty minutes of ingestion.
- Task Initiation DriveOvercomes heavy cognitive inertia and task avoidance, allowing prompt engagement with high-friction projects.
- Clean Metabolic ClearanceTapers off cleanly after three to four hours without lingering sedation or systemic hangover.
Secondary Reactions & Cautions
The following physiological responses are documented during active administration:
- Transient Adrenergic PulseA short-lived increase in heart rate during the initial twenty-minute plasma uptake phase.
- Acute Appetite SuppressionBrief blunting of hunger cues while active compound circulates.
- Focal ActivationMild physical alertness that resolves as plasma concentrations settle into steady therapeutic levels.
Administration Protocol: Administer in the morning upon waking with water. Keep a small morning meal scheduled to maintain balanced blood sugar during peak uptake.
Testing & Sampling Status
Notice: This stuff is real, not fake, and we are currently in the active testing and sampling phase.
All formulations are synthesized and prepared under strict laboratory conditions in Perth, Western Australia. Inquiries for testing dossiers, institutional sampling batches, and analytical specifications should be directed to the engineering team.
Contact hello@caissonai.co or human@caissonai.co for sampling inquiries.